205
Participants
Start Date
March 31, 2009
Primary Completion Date
January 31, 2018
Study Completion Date
August 30, 2018
Etanercept
etanercept 0.8 mg/kg subcutaneously (max 50 mg) given three times, once a week for three weeks starting at initial diagnosis.
Placebo
Placebo 0.8 mg/kg subcutaneously (max 50 mg) given three times, once a week for three weeks starting at initial diagnosis.
Columbia University Medical Center, New York
Montefiore Medical Center, The Bronx
Feinstein Institute for Medical Rsearch, New Hyde Park
Children's Hospital of Wisconsin, Milwaukee
Texas Children's Hospital, Houston
Primary Children's Medical Center, Salt Lake City
Seattle Children's Hospital, Seattle
Sainte-Justine Hospital, Montreal
Collaborators (1)
Amgen
INDUSTRY
Michael Portman
OTHER